Phillip E. Korenblat

Author

Also Known As

P Korenblat, P. E. Korenblat, P. Korenblat, P.E. Korenblat, PHILLIP E. KORENBLAT, Phillip E Korenblat, Phillip E. Korenblat, Phillip Korenblat

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Baylor College of Medicine Allergy Associates Research Center Washington University in St. Louis AstraZeneca (United States)Jewish Hospital

About

Phillip E. Korenblat is an author at Baylor College of Medicine specializing in medicine, allergy, and asthma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	1.6K
2	Allergy	10	10	1.3K
3	Allergy Medicine	5	5	857
4	Health Sciences	1	1	20
5	Clinical Immunology	1	1	138

Phillip E. Korenblat

Publications

Citations

H-Index

Page 1

	Year	Citations
Lebrikizumab Treatment in Adults with Asthma Jonathan Corren, Robert F. Lemanske, Nicola A. Hanania, New England Journal of Medicine	2011	1.5K
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials Nicola A. Hanania, Phillip E. Korenblat, Kenneth R. Chapman, The Lancet Respiratory Medicine AsthmaRheumatologyAllergyAllergy MedicinePharmacology	2016	463
The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease Stephen I. Rennard, Charles Fogarty, Steven G. Kelsen, American Journal of Respiratory and Critical Care Medicine	2007	426
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies Nicola A. Hanania, Michael Noonan, Jonathan Corren, Thorax	2015	374
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids Michael Noonan, Phillip E. Korenblat, Sofia Mosesova, Journal of Allergy and Clinical Immunology AsthmaAllergyAllergy MedicinePharmacologyPulmonary Pharmacology	2013	168
Immune responses of human adults after oral and parenteral exposure to bovine serum albumin Phillip E. Korenblat, Richard M. Rothberg, Percy Minden, Journal of Allergy Clinical ImmunologyInflammationMaternal ImmunizationAllergyAnimal Science	1968	138
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study Andrew Menzies‐Gow, Michael E. Wechsler, Christopher E. Brightling, The Lancet Respiratory Medicine AsthmaRheumatologyAllergyClinical TrialsUncontrolled Asthma	2023	127
Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency Chaim M. Roifman, Harry W. Schroeder, Melvin Berger, International Immunopharmacology Primary ImmunodeficiencyPrimary Immune DeficiencyAutoimmune DiseaseAllergyImmunodeficiencies	2003	120
A Retrospective Study of Epinephrine Administration for Anaphylaxis: How Many Doses Are Needed? Phillip E. Korenblat, Mark Lundie, Rand E. Dankner, Allergy and Asthma Proceedings AsthmaEpinephrine InjectionAllergy MedicinePharmacotherapyDrug Allergy	1999	118
Zafirlukast Treatment for Acute Asthma Robert A. Silverman, Richard M. Nowak, Phillip E. Korenblat, CHEST Journal AsthmaAllergy MedicinePulmonary PharmacologyPharmacotherapyMedicine	2004	87

Page 1